- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 24th, 2007
Preserving organs and killing cancer cells with products that employ nanotechnology—the emerging science of manufacturing at the molecular level—were the hot topics last week when the New Jersey Technology Council sponsored a forum on one of the latest trends in biomedical research.
The Philadelphia gathering of 25 executives, scientists and other members of the health care community heard how nanotechnology is being used to make and develop biomedical devices and drugs. The science, which takes place on the scale of one billionth of a meter, is slowly leaving federally funded laboratories and making its way into fields ranging from retail to medicine.
Panelist Joseph Fischer, chairman and CEO of Lifeblood Medical Inc. in Adelphia, says his company employs nanotechnology to make Lifor, a liquid that preserves organs used for transplants, and to make LiforCell, which preserves tissues and cells used in laboratory experiments. He says the U.S. Navy is testing Lifor for limb preservation.
|Related News Press|
Feynman Prize Winners Announced! April 26th, 2015
Heat makes electrons’ spin in magnetic superconductors April 26th, 2015
Electron spin brings order to high entropy alloys April 23rd, 2015
Engineer improves rechargeable batteries with MoS2 nano 'sandwich' April 18th, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015